About

I've always been drawn to the immune system's capacity for both protection and harm — and the question of whether we can tip that balance intentionally.

That question led me from Miami to Chicago to New York, through protein engineering, computational biology, and mouse models, all in pursuit of one goal: teaching the immune system to choose tolerance.

Education

Ph.D., Molecular Engineering

University of Chicago, Pritzker School of Molecular Engineering

Advisor: Jeffrey A. Hubbell

Dissertation: Recombinant Fusions of Antigen with Mediators of Efferocytosis Modulate Antigen-Specific Immune Responses

B.S., Summa Cum Laude

University of Miami

High School

Illinois Mathematics & Science Academy

Technical Expertise

Wet Lab

Protein Engineering Molecular Biology Flow Cytometry (20+ colors) Mouse Models OT-I/OT-II Systems

Computational

High-dimensional Flow Analysis FlowJo R/Bioconductor scRNA-seq (Seurat, Scanpy) Multi-omics Integration Python

Research Focus

My research centers on the hypothesis that efferocytosis — the process by which phagocytes clear apoptotic cells — can be leveraged to induce immunological tolerance in a targeted and antigen-specific manner.

By designing proteins that engage efferocytic pathways while presenting specific antigens, we can potentially treat autoimmune diseases and allergies without the broad immunosuppression of current therapies.